Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-013833
Filing Date
2023-12-19
Accepted
2023-12-19 12:36:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27662
2 filename2.txt TEXT-EXTRACT 1512
  Complete submission text file 0000000000-23-013833.txt   40309
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filed for) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)